search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Contents


23 Precision micro-dosing for clinical development PCI Pharma Services


25 The real-world impact of data gaps in clinical trials TSS


27 The evolving environment of clinical trial sourcing Myonex


29 Effective comparator sourcing amid a pandemic Clinigen Clinical Supplies Management


30 Go to waste


The supply slowdowns caused by the pandemic highlighted the importance of building redundancy and flexibility into the supply chain. A Herculean effort to keep clinical trials going focused the industry on cost- efficiency and the risk of waste, while in the background long-term issues such as climate change accentuated the same issues. Jim Banks speaks to Steven Jacobs, chairman of the board at Global BioPharm Solutions and a board member of the Global Clinical Supplies Group (GCSG), and Aaron Steinbrecher, clinical supply project manager at AbbVie, to examine how sponsors overcame the challenges presented by the pandemic, and how this will shape a more sustainable and efficient approach in the future.


Clinical Trials Insight / www.worldpharmaceuticals.net


Outsourcing


30


33 Virtual trial and error To withstand the disruption seen during Covid-19, clinical trials need to be responsive to the needs and abilities of all stakeholders. As more and more research moves out of the clinic and into the home, Lynette Eyb speaks to Mads Dalsgaard, senior vice-president, head of experimental medicine and clinical development at Lundbeck, about decentralisation and the challenges of operating trials in a virtual setting.


37 Hybrid FIH trials: 40


Advantages and challenges SGS


39 Managing vendors means managing relationships Lumis Life Science Consulting


Clinical data management 40 Remote control


Increased use of mobile apps in clinical trials promises interconnected ecosystems, faster studies, and access to continuous data all at the touch of a button. But how crucial are these apps in the wider landscape of emerging digital healthcare technologies? Mae Losasso speaks to John Zibert, CEO of Studies&Me, Leonard Sacks, associate director for clinical methodology at the FDA, and Ryan Shaw, faculty lead on Duke University Mobile App Gateway, to find out more.


33


5


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45